Adjusted background Scibase

Creating a new standard in skin barrier assessment

iStock-1137515007 [Converted]

The challenge:

Researchers simply do not have the tools to identify skin barrier function in a simple, objective manner.


20% of infants develop AD

They are up to 7 times more likely to develop asthma and allergies.


7% of adults suffer from atopic diseases

40% of them experience chronic symptoms, and some of those debilitating pain.

Skin Barrier Assessment: A new level of insight

Nevisense Skin Barrier Assessment brings new level of insight into the skin barrier fuction, contributing to studies involving inflammation and allergy, wound healing, and even cosmetics. 

Allergies, flaking and wounds, atopic dermatitis on the face


  • Effective, efficient and Reproducible
  • AI-driven
  • 20+ years of research and 85+ publications
  • More robust than TEWL, and less sensitive to artifacts 


Why the skin barrier matters

Skin Barrier dysfuction is closely connected to diseases such as atopic dermatitis (AD), asthma, chronic rhinosinusitis, allergic rhinitis, esophagitis, and colitis.

Atopic Dermatitis


Nevisense is less influenced by daily activities than TEWL

Download here


Nevisense assesses skin barrier integrity in pre-clinical skin models

Download here


Nevisense detects skin barrier dysfunction in children with Atopic Dermatitis

Download here


Nevisense characterizes skin barrier function in Atopic Dermatitis patients

Download here

"I work every day with the management of different allergic diseases in children, and it is a growing problem. Allergic diseases have a natural progression with atopic dermatitis being the first to manifest, often already in infancy, followed by other allergic diseases, such as food allergy and allergic asthma. The ability to identify these children early will help to develop preventive strategies for allergic diseases, and Nevisense is an extremely promising method that has potential for early prediction of those children."

Dr. Caroline Roduit

PD Dr. med., PhD, University of Zurich | UZH · Children’s Hospital of Eastern Switzerland.

Caroline Roduit croped

Our corporate site

Visit to learn more on how Nevisense is beeing used in all indications. 

Read more

Our Investor site

Visit our investor site to learn more on oppertinities with SciBase and Nevisense.

Read more




Nevisense has been included in over 85 published studies. Download our publication list here. 

Download here

Adjusted background Scibase
iStock-1137515007 [Converted]

Nevisense: a new objective standard to measure and manage skin barrier fuction.

Contact us

"*" indicates required fields

Find us

Landsvägen 39
172 63 Sundbyberg

+46 8 410 620 00